Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fentanyl recalled?

Yes — there is an active recall. 22 ongoing FDA recalls mention Fentanyl (357 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fentanyl. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fentanyl recalls on record

none so far in 2026; 357 on record, newest first
Class II · Moderate risk

fentaNYL 400 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1440-76 D-0554-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1225-37 D-0552-2020
Class II · Moderate risk

fentaNYL 1500 mcg/30 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1099-49 D-0551-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1104-36 D-0550-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1269-37 D-0549-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1259-75 D-0548-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1105-37 D-0547-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1160-37 D-0546-2020
Class II · Moderate risk

PF-Fentanyl Citrate

GMP Deviations: potential glass contamination

Terminated cGMP deviation Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk

Fentanyl Citrate USP

CGMP Deviations: Received notice from supplier that there is potential glass contamination.

Terminated cGMP deviation Spectrum Laboratory Products NDC 49452-0032-06 D-0141-2020
Class II · Moderate risk

Fentanyl Citrate in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0586-2020